Chakrabarti demonstrated that an attenuated Id2-kd whole-cell neuroblastoma vaccine was safe in mice and could induce a broad tumor-specific cellular immunity, which protected against tumor formation in prophylactic tumor models and eradicated large established neuroblastoma tumors in combination with an anti-CTLA-4 antibody [31]. The gene discussed is ID2; the disease is neoplasm.